SCHEMBL20202032

SCHEMBL20202032

CN1c2ccccc2C2(c3ccccc31)c1ccccc1N1c3ccccc3C3(c4ccccc4N(C)c4ccccc43)c3cccc2c31

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.38
KDM4E B2RXH2 5/20 0.38
HTT P42858 5/20 0.38
LMNA P02545 4/20 0.38
HCRTR1 O43613 1/20 0.38
MAOA P21397 1/20 0.36
MEN1 O00255 7/20 0.36
KMT2A Q03164 7/20 0.36
MAPK1 P28482 1/20 0.36
AKR1B1 P15121 1/20 0.34
RAD52 P43351 1/20 0.34
ALDH1A1 P00352 3/20 0.33
THRB P10828 2/20 0.33
RECQL P46063 2/20 0.33
GAA P10253 2/20 0.33
TSHR P16473 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20202031 0.94 MAPT (0.39) MAPTKDM4EHTTLMNAHCRTR1
SCHEMBL20202033 0.84 TSHR (0.36) MAPTKDM4EHTTLMNAHCRTR1
SCHEMBL20202030 0.83 TSHR (0.35) MAPTKDM4EHTTLMNAHCRTR1
SCHEMBL20938469 0.82 MEN1 (0.38) MAPTKDM4ELMNAMEN1KMT2A
SCHEMBL20202037 0.81 ALDH1A1 (0.39) MEN1KMT2AMAPK1ALDH1A1GAA
SCHEMBL20202034 0.81 ALDH1A1 (0.39) MAPTKDM4EHTTLMNAHCRTR1
SCHEMBL20202025 0.80 TSHR (0.35) MAPTKDM4EHTTLMNAHCRTR1
SCHEMBL21009067 0.79 ALDH1A1 (0.38) MAPTKDM4EHTTLMNAHCRTR1
SCHEMBL19035959 0.78 LMNA (0.36) MAPTKDM4ELMNAMEN1KMT2A
SCHEMBL23056710 0.78 HTT (0.49) MAPTKDM4EHTTLMNAHCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10787467-B2 Polycyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-09-29 US disclosed
US-20180148462-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-31 US disclosed
US-20180148462-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180148462-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME PKD1, ODC1, PIEZO1 MAPT 2422/4885KDM4E 2822/4885HTT 2772/4885
US-10787467-B2 Polycyclic compound and organic electroluminescence device including the same PKD1, ODC1, PIEZO1 MAPT 2422/4885KDM4E 2822/4885HTT 2772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.